<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1" />

<meta name="author" content="Assaf Oron" />

<meta name="date" content="2024-12-02" />

<title>Vignette for the cir Package</title>

<script>// Pandoc 2.9 adds attributes on both header and div. We remove the former (to
// be compatible with the behavior of Pandoc < 2.8).
document.addEventListener('DOMContentLoaded', function(e) {
  var hs = document.querySelectorAll("div.section[class*='level'] > :first-child");
  var i, h, a;
  for (i = 0; i < hs.length; i++) {
    h = hs[i];
    if (!/^h[1-6]$/i.test(h.tagName)) continue;  // it should be a header h1-h6
    a = h.attributes;
    while (a.length > 0) h.removeAttribute(a[0].name);
  }
});
</script>

<style type="text/css">
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
</style>



<style type="text/css">
code {
white-space: pre;
}
.sourceCode {
overflow: visible;
}
</style>
<style type="text/css" data-origin="pandoc">
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { display: inline-block; text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
{ counter-reset: source-line 0; }
pre.numberSource code > span
{ position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
{ content: counter(source-line);
position: relative; left: -1em; text-align: right; vertical-align: baseline;
border: none; display: inline-block;
-webkit-touch-callout: none; -webkit-user-select: none;
-khtml-user-select: none; -moz-user-select: none;
-ms-user-select: none; user-select: none;
padding: 0 4px; width: 4em;
color: #aaaaaa;
}
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa; padding-left: 4px; }
div.sourceCode
{ }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } 
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.at { color: #7d9029; } 
code span.bn { color: #40a070; } 
code span.bu { color: #008000; } 
code span.cf { color: #007020; font-weight: bold; } 
code span.ch { color: #4070a0; } 
code span.cn { color: #880000; } 
code span.co { color: #60a0b0; font-style: italic; } 
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.do { color: #ba2121; font-style: italic; } 
code span.dt { color: #902000; } 
code span.dv { color: #40a070; } 
code span.er { color: #ff0000; font-weight: bold; } 
code span.ex { } 
code span.fl { color: #40a070; } 
code span.fu { color: #06287e; } 
code span.im { color: #008000; font-weight: bold; } 
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.kw { color: #007020; font-weight: bold; } 
code span.op { color: #666666; } 
code span.ot { color: #007020; } 
code span.pp { color: #bc7a00; } 
code span.sc { color: #4070a0; } 
code span.ss { color: #bb6688; } 
code span.st { color: #4070a0; } 
code span.va { color: #19177c; } 
code span.vs { color: #4070a0; } 
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } 
</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    var j = 0;
    while (j < rules.length) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") {
        j++;
        continue;
      }
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') {
        j++;
        continue;
      }
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>




<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; } 
code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">Vignette for the <code>cir</code>
Package</h1>
<h3 class="subtitle">Using Up-and-Down data from Benhamou et
al. (2003)</h3>
<h4 class="author">Assaf Oron</h4>
<h4 class="date">2024-12-02</h4>



<div id="overview" class="section level2">
<h2>Overview</h2>
<p>I demonstrate the <code>cir</code> package with data from the
anesthesiology experiment of Benhamou et al. (2003)<a href="#fn1" class="footnote-ref" id="fnref1"><sup>1</sup></a>. This experiment used
the Up-and-Down (UD) dose-finding design, and was re-analyzed a few
years later by Pace and Stylianou (2007).<a href="#fn2" class="footnote-ref" id="fnref2"><sup>2</sup></a> Here I re-analyze the
dataset yet again, using state-of-the-art Centered Isotonic Regression
(CIR),<a href="#fn3" class="footnote-ref" id="fnref3"><sup>3</sup></a>
the core estimator found in our package.</p>
<p>Up-and-down data analysis was the original motivation for developing
CIR and <code>cir</code>. For a general overview of UD designs, see Oron
et al. 2022.<a href="#fn4" class="footnote-ref" id="fnref4"><sup>4</sup></a> However, the package is compatible with any
binary-outcome data for which a monotone dose-response relationship is
expected - regardless of design. The <code>cir</code> package includes
methods for both <strong>“forward”</strong> estimation, i.e., the
expected response rate conditional on dose, and
<strong>“inverse”</strong> estimation, a.k.a. dose-finding. Both
estimation directions have quick, more user-friendly all-in-one
functions, and more detailed in-depth functions.</p>
<p>If your interest is mainly in UD data analysis, then you are
encouraged to use the dedicated UD package <code>upndown</code>. It
includes wrappers for even simpler, single-command plotting and
estimation of UD datasets, using <code>cir</code> package functions with
the defaults already dialed onto the UD context. You can download the
latest version of that package using
<code>remotes::install_github(assaforon/upndown)</code>. CRAN also has a
copy but it would always be a couple of steps back, as
<code>upndown</code> is still new and changing a lot.</p>
</div>
<div id="the-study-in-our-example" class="section level2">
<h2>The Study in our Example</h2>
<p>Benhamou et al. (2003) randomized pregnant volunteers in labor into
two groups, receiving as analgesic either ropivacaine or
levobupivacaine, to estimate each agent’s median effective dose (ED<span class="math inline">\(_{50}\)</span>) for this condition, and to test
whether there is significant difference in equal-concentration efficacy
by comparing the two estimates. The original study used a “traditional”
UD dose-averaging estimation method, concluding that even though
levobupivacaine seemed 19% more potent, the difference between ED<span class="math inline">\(_{50}\)</span>s was not significant. To derive
inference about this difference, they apparently used the standard
errors of dose averages in a <span class="math inline">\(t\)</span>-test
like manner.</p>
<p>Pace and Stylianou (2007) re-analyzed the data using isotonic
regression (IR) and <span class="math inline">\(83\%\)</span> bootstrap
confidence intervals (CIs); under certain assumptions, examining whether
these CIs overlap is equivalent to rejecting the Null hypothesis with
<span class="math inline">\(\alpha = 0.05.\)</span> <a href="#fn5" class="footnote-ref" id="fnref5"><sup>5</sup></a> They found a larger
difference: levobupivacaine was 37% more potent according to the IR
estimates. Furthermore, the difference was deemed statistically
significant because the <span class="math inline">\(83\%\)</span> CIs
did not overlap.</p>
<p>Here we revisit this experiment yet again. To reduce some confusion,
we drop the percent sign from description of doses used <em>(they were
given as concentrations in percent in the original)</em>.</p>
</div>
<div id="experimental-trajectories" class="section level2">
<h2>Experimental Trajectories</h2>
<p>We do not have the original data table, nor do the original authors
have access to it anymore; but we can read the sequence of administered
doses off of Benhamou et al.’s Figure 1.</p>
<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb1-1"><a href="#cb1-1" tabindex="-1"></a><span class="co"># For brevity, we initially use integers to denote the doses. </span></span>
<span id="cb1-2"><a href="#cb1-2" tabindex="-1"></a></span>
<span id="cb1-3"><a href="#cb1-3" tabindex="-1"></a>xropi <span class="ot">=</span> <span class="fu">c</span>(<span class="dv">11</span><span class="sc">:</span><span class="dv">9</span>,<span class="dv">10</span><span class="sc">:</span><span class="dv">8</span>,<span class="dv">9</span>,<span class="dv">10</span>,<span class="dv">9</span>,<span class="dv">10</span><span class="sc">:</span><span class="dv">7</span>,<span class="dv">8</span><span class="sc">:</span><span class="dv">11</span>,<span class="dv">10</span><span class="sc">:</span><span class="dv">12</span>,<span class="dv">11</span><span class="sc">:</span><span class="dv">7</span>,<span class="dv">8</span>,<span class="dv">7</span><span class="sc">:</span><span class="dv">10</span>,<span class="dv">9</span>,<span class="dv">8</span>,<span class="dv">9</span>,<span class="dv">8</span><span class="sc">:</span><span class="dv">10</span>,<span class="dv">9</span>,<span class="dv">10</span>,<span class="dv">9</span>,<span class="dv">10</span>)</span>
<span id="cb1-4"><a href="#cb1-4" tabindex="-1"></a>xlevo <span class="ot">=</span> <span class="fu">c</span>(<span class="dv">11</span>,<span class="dv">10</span>,<span class="dv">11</span>,<span class="dv">10</span>,<span class="dv">11</span><span class="sc">:</span><span class="dv">9</span>,<span class="dv">10</span><span class="sc">:</span><span class="dv">7</span>,<span class="dv">8</span>,<span class="dv">7</span>,<span class="dv">8</span><span class="sc">:</span><span class="dv">5</span>,<span class="dv">6</span><span class="sc">:</span><span class="dv">8</span>,<span class="dv">7</span>,<span class="dv">8</span><span class="sc">:</span><span class="dv">6</span>,<span class="dv">7</span>,<span class="dv">6</span>,<span class="dv">7</span>,<span class="dv">6</span>,<span class="dv">7</span><span class="sc">:</span><span class="dv">5</span>,<span class="dv">6</span>,<span class="dv">7</span>,<span class="dv">6</span><span class="sc">:</span><span class="dv">12</span>)</span></code></pre></div>
<p>The study design being <em>“classical”</em> or median-finding UD, the
responses (<span class="math inline">\(y\)</span>) can be read off
directly from the doses (<span class="math inline">\(x\)</span>): a
positive increment indicates no effectiveness (<span class="math inline">\(y=0\)</span>), and vice versa. Symbolically, <span class="math display">\[y = \left( 1-diff(x) \right) / 2.\]</span> We use
this and the <code>DRtrace()</code> constructor utility, to create
objects that store doses (converted to their physical units) and
responses; as we call them here, the experimental “trace” or
<strong>trajectory.</strong></p>
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb2-1"><a href="#cb2-1" tabindex="-1"></a><span class="fu">library</span>(cir)</span>
<span id="cb2-2"><a href="#cb2-2" tabindex="-1"></a>bhamou03ropi <span class="ot">=</span> <span class="fu">DRtrace</span>(<span class="at">x=</span>xropi[<span class="sc">-</span><span class="dv">40</span>]<span class="sc">/</span><span class="dv">100</span>, <span class="at">y=</span>(<span class="dv">1</span><span class="sc">-</span><span class="fu">diff</span>(xropi))<span class="sc">/</span><span class="dv">2</span>)</span>
<span id="cb2-3"><a href="#cb2-3" tabindex="-1"></a>bhamou03levo <span class="ot">=</span> <span class="fu">DRtrace</span>(<span class="at">x=</span>xlevo[<span class="sc">-</span><span class="dv">40</span>]<span class="sc">/</span><span class="dv">100</span>, <span class="at">y=</span>(<span class="dv">1</span><span class="sc">-</span><span class="fu">diff</span>(xlevo))<span class="sc">/</span><span class="dv">2</span>)</span></code></pre></div>
<p>In the construction above, we gave up the 40th and last observation
in each arm, because we only know its dose but not the response. Since
UD datasets (and more generally, small-sample dose-response datasets)
are rather compact, as shown above entering the data takes no more than
2-3 lines of code. But you can also use <code>.csv</code> file input if
preferred, with two columns headed <code>x</code> and
<code>y</code>.</p>
<p><code>DRtrace</code> objects have a native plotting method:</p>
<div class="sourceCode" id="cb3"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb3-1"><a href="#cb3-1" tabindex="-1"></a><span class="fu">par</span>(<span class="at">mfrow=</span><span class="fu">c</span>(<span class="dv">1</span>,<span class="dv">2</span>), <span class="at">las=</span><span class="dv">1</span>, <span class="at">mar=</span><span class="fu">c</span>(<span class="dv">4</span>,<span class="dv">4</span>,<span class="dv">4</span>,<span class="dv">1</span>)) <span class="co"># image format parameters</span></span>
<span id="cb3-2"><a href="#cb3-2" tabindex="-1"></a>doserange <span class="ot">=</span> <span class="fu">c</span>(<span class="dv">5</span>,<span class="dv">12</span>)<span class="sc">/</span><span class="dv">100</span></span>
<span id="cb3-3"><a href="#cb3-3" tabindex="-1"></a></span>
<span id="cb3-4"><a href="#cb3-4" tabindex="-1"></a><span class="fu">plot</span>(bhamou03ropi, <span class="at">ylim=</span>doserange, <span class="at">ylab=</span><span class="st">&quot;Concentration (%)&quot;</span>, <span class="at">main=</span><span class="st">&#39;Ropivacaine Arm&#39;</span>)</span>
<span id="cb3-5"><a href="#cb3-5" tabindex="-1"></a><span class="fu">legend</span>(<span class="st">&#39;bottomright&#39;</span>,<span class="at">legend=</span><span class="fu">c</span>(<span class="st">&#39;Effective&#39;</span>,<span class="st">&#39;Ineffective&#39;</span>),<span class="at">pch=</span><span class="fu">c</span>(<span class="dv">19</span>,<span class="dv">1</span>),<span class="at">bty=</span><span class="st">&#39;n&#39;</span>)</span>
<span id="cb3-6"><a href="#cb3-6" tabindex="-1"></a><span class="fu">plot</span>(bhamou03levo, <span class="at">ylim=</span>doserange, <span class="at">ylab=</span><span class="st">&quot;Concentration (%)&quot;</span>, <span class="at">main=</span><span class="st">&#39;Levobupivacaine Arm&#39;</span>)</span></code></pre></div>
<p><img role="img" src="data:image/png;base64,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" width="800" height="400" /></p>
<p>The “traditional” estimates in the original articles, just used some
type of average of the doses administered. This is based on the premise
that over time, up-and-down designs concentrate these doses roughly
symmetrically around the target percentile.</p>
<p>Generally speaking, the “traditional” estimates are rather outdated
and lack robustness. We recommend CIR as the standard estimator for
up-and-down experiments (see e.g., <a href="https://cdn-links.lww.com/permalink/aln/c/aln_2022_05_25_oron_aln-d-21-01101_sdc1.pdf">Oron
et al. 2022 supplement (pdf link)</a>).</p>
</div>
<div id="dose-response-plot-and-ed_50-estimates" class="section level2">
<h2>Dose-Response Plot and ED<span class="math inline">\(_{50}\)</span>
Estimates</h2>
<p>To derive CIR estimates, we take the <code>DRtrace</code> trajectory
objects and generate <code>doseResponse</code> dose-rate-count
summaries.</p>
<div class="sourceCode" id="cb4"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb4-1"><a href="#cb4-1" tabindex="-1"></a>bhamou03ropiRates <span class="ot">=</span> <span class="fu">doseResponse</span>(bhamou03ropi)</span>
<span id="cb4-2"><a href="#cb4-2" tabindex="-1"></a>bhamou03levoRates <span class="ot">=</span> <span class="fu">doseResponse</span>(bhamou03levo)</span>
<span id="cb4-3"><a href="#cb4-3" tabindex="-1"></a>knitr<span class="sc">::</span><span class="fu">kable</span>(bhamou03ropiRates, <span class="at">row.names=</span><span class="cn">FALSE</span>,<span class="at">align=</span><span class="st">&#39;ccr&#39;</span>,<span class="at">digits=</span><span class="fu">c</span>(<span class="dv">2</span>,<span class="dv">4</span>,<span class="dv">0</span>))</span></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="center">x</th>
<th align="center">y</th>
<th align="right">weight</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="center">0.07</td>
<td align="center">0.0000</td>
<td align="right">3</td>
</tr>
<tr class="even">
<td align="center">0.08</td>
<td align="center">0.3750</td>
<td align="right">8</td>
</tr>
<tr class="odd">
<td align="center">0.09</td>
<td align="center">0.3846</td>
<td align="right">13</td>
</tr>
<tr class="even">
<td align="center">0.10</td>
<td align="center">0.8000</td>
<td align="right">10</td>
</tr>
<tr class="odd">
<td align="center">0.11</td>
<td align="center">0.7500</td>
<td align="right">4</td>
</tr>
<tr class="even">
<td align="center">0.12</td>
<td align="center">1.0000</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
<div class="sourceCode" id="cb5"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb5-1"><a href="#cb5-1" tabindex="-1"></a>knitr<span class="sc">::</span><span class="fu">kable</span>(bhamou03levoRates, <span class="at">row.names=</span><span class="cn">FALSE</span>,<span class="at">align=</span><span class="st">&#39;ccr&#39;</span>,<span class="at">digits=</span><span class="fu">c</span>(<span class="dv">2</span>,<span class="dv">4</span>,<span class="dv">0</span>))</span></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="center">x</th>
<th align="center">y</th>
<th align="right">weight</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="center">0.05</td>
<td align="center">0.0000</td>
<td align="right">2</td>
</tr>
<tr class="even">
<td align="center">0.06</td>
<td align="center">0.2500</td>
<td align="right">8</td>
</tr>
<tr class="odd">
<td align="center">0.07</td>
<td align="center">0.5455</td>
<td align="right">11</td>
</tr>
<tr class="even">
<td align="center">0.08</td>
<td align="center">0.8333</td>
<td align="right">6</td>
</tr>
<tr class="odd">
<td align="center">0.09</td>
<td align="center">0.3333</td>
<td align="right">3</td>
</tr>
<tr class="even">
<td align="center">0.10</td>
<td align="center">0.4000</td>
<td align="right">5</td>
</tr>
<tr class="odd">
<td align="center">0.11</td>
<td align="center">0.7500</td>
<td align="right">4</td>
</tr>
</tbody>
</table>
<p>Let us visualize the response frequencies on <strong>the
dose-response plane, which is “where CIR estimation action
happens.”</strong> <em>(and likewise for any regression-based estimation
of dose-response data)</em></p>
<p>Analogously to the plots above, the plots below are native
<code>cir</code> methods for <code>doseResponse</code> objects. Symbol
area is proportional to the number of observations at each dose. To
change to fixed-size, use <code>varsize=FALSE</code>.</p>
<div class="sourceCode" id="cb6"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb6-1"><a href="#cb6-1" tabindex="-1"></a><span class="fu">par</span>(<span class="at">mfrow=</span><span class="fu">c</span>(<span class="dv">1</span>,<span class="dv">2</span>), <span class="at">las=</span><span class="dv">1</span>, <span class="at">mar=</span><span class="fu">c</span>(<span class="dv">4</span>,<span class="dv">4</span>,<span class="dv">4</span>,<span class="dv">1</span>)) <span class="co"># image format parameters</span></span>
<span id="cb6-2"><a href="#cb6-2" tabindex="-1"></a><span class="fu">plot</span>(bhamou03ropiRates, <span class="at">xlab=</span><span class="st">&quot;Concentration (%)&quot;</span>, </span>
<span id="cb6-3"><a href="#cb6-3" tabindex="-1"></a><span class="at">ylab=</span><span class="st">&quot;Proportion Effective&quot;</span>, <span class="at">main=</span><span class="st">&#39;Ropivacaine Arm&#39;</span>, <span class="at">ylim=</span><span class="dv">0</span><span class="sc">:</span><span class="dv">1</span>)</span>
<span id="cb6-4"><a href="#cb6-4" tabindex="-1"></a><span class="co"># Showing the target response rate</span></span>
<span id="cb6-5"><a href="#cb6-5" tabindex="-1"></a><span class="fu">abline</span>( <span class="at">h=</span><span class="fl">0.5</span>, <span class="at">col=</span><span class="st">&#39;purple&#39;</span>, <span class="at">lty=</span><span class="dv">2</span>)</span>
<span id="cb6-6"><a href="#cb6-6" tabindex="-1"></a></span>
<span id="cb6-7"><a href="#cb6-7" tabindex="-1"></a><span class="fu">plot</span>(bhamou03levoRates, <span class="at">xlab=</span><span class="st">&quot;Concentration (%)&quot;</span>, </span>
<span id="cb6-8"><a href="#cb6-8" tabindex="-1"></a><span class="at">ylab=</span><span class="st">&quot;Proportion Effective&quot;</span>, <span class="at">main=</span><span class="st">&#39;Levobupivacaine Arm&#39;</span>, <span class="at">ylim=</span><span class="dv">0</span><span class="sc">:</span><span class="dv">1</span>)</span>
<span id="cb6-9"><a href="#cb6-9" tabindex="-1"></a></span>
<span id="cb6-10"><a href="#cb6-10" tabindex="-1"></a><span class="fu">abline</span>( <span class="at">h=</span><span class="fl">0.5</span>, <span class="at">col=</span><span class="st">&#39;purple&#39;</span>, <span class="at">lty=</span><span class="dv">2</span>)</span></code></pre></div>
<p><img role="img" src="data:image/png;base64,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" width="800" height="400" /></p>
<p>Target-dose estimation via regression is an <a href="https://en.wikipedia.org/wiki/Inverse_problem"><strong>“Inverse
Problem”</strong></a>: we draw a line at the desired <span class="math inline">\(y\)</span> value (in this case, <span class="math inline">\(50\%\)</span> or 0.5, marked in purple), and look
for the best-fitting <span class="math inline">\(x\)</span> value. With
the Ropivacaine arm data (left), there’s a relatively clear transition
between low-response and high-response regions, so the target seems to
lie between concentrations <span class="math inline">\(0.09\)</span> and
<span class="math inline">\(0.10\)</span>. We cannot be very confident
of that, given the limited amount of information - but at least there’s
a clear candidate.</p>
<p>With Levobupivacaine data (right) the picture is far more murky.
Concentrations <span class="math inline">\(0.07\)</span> and <span class="math inline">\(0.08\)</span> go above <span class="math inline">\(50\%\)</span> response, but <span class="math inline">\(0.09\)</span> and <span class="math inline">\(0.10\)</span> go back below that level! As we
visualize further below, CIR helps clear that murky picture via the
simplest pooled response-rate averages that makes the overall
dose-response curve obey monotonicity.</p>
<p>But before going behind the scenes: from the
<code>doseResponse</code> object, CIR estimation of <span class="math inline">\(F(x)\)</span> is only one step away.</p>
<div class="sourceCode" id="cb7"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb7-1"><a href="#cb7-1" tabindex="-1"></a><span class="fu">quickIsotone</span>(bhamou03ropiRates, <span class="at">target=</span><span class="fl">0.5</span>, <span class="at">adaptiveShrink=</span><span class="cn">TRUE</span>)</span>
<span id="cb7-2"><a href="#cb7-2" tabindex="-1"></a><span class="co">#         x         y lower90conf upper90conf</span></span>
<span id="cb7-3"><a href="#cb7-3" tabindex="-1"></a><span class="co"># 0.07 0.07 0.1250000  0.01388341   0.4566917</span></span>
<span id="cb7-4"><a href="#cb7-4" tabindex="-1"></a><span class="co"># 0.08 0.08 0.3888889  0.17029265   0.6144262</span></span>
<span id="cb7-5"><a href="#cb7-5" tabindex="-1"></a><span class="co"># 0.09 0.09 0.3928571  0.20777116   0.6148574</span></span>
<span id="cb7-6"><a href="#cb7-6" tabindex="-1"></a><span class="co"># 0.1  0.10 0.6721501  0.46544685   0.8286039</span></span>
<span id="cb7-7"><a href="#cb7-7" tabindex="-1"></a><span class="co"># 0.11 0.11 0.8553030  0.55419939   0.9356434</span></span>
<span id="cb7-8"><a href="#cb7-8" tabindex="-1"></a><span class="co"># 0.12 0.12 1.0000000  0.57538267   1.0000000</span></span>
<span id="cb7-9"><a href="#cb7-9" tabindex="-1"></a><span class="fu">quickIsotone</span>(bhamou03levoRates, <span class="at">target=</span><span class="fl">0.5</span>, <span class="at">adaptiveShrink=</span><span class="cn">TRUE</span>)</span>
<span id="cb7-10"><a href="#cb7-10" tabindex="-1"></a><span class="co">#         x         y lower90conf upper90conf</span></span>
<span id="cb7-11"><a href="#cb7-11" tabindex="-1"></a><span class="co"># 0.05 0.05 0.1666667  0.01687173   0.4598125</span></span>
<span id="cb7-12"><a href="#cb7-12" tabindex="-1"></a><span class="co"># 0.06 0.06 0.2777778  0.10187230   0.5556723</span></span>
<span id="cb7-13"><a href="#cb7-13" tabindex="-1"></a><span class="co"># 0.07 0.07 0.5416667  0.31190997   0.7406421</span></span>
<span id="cb7-14"><a href="#cb7-14" tabindex="-1"></a><span class="co"># 0.08 0.08 0.5542328  0.34408940   0.7480747</span></span>
<span id="cb7-15"><a href="#cb7-15" tabindex="-1"></a><span class="co"># 0.09 0.09 0.5705255  0.37555944   0.7607139</span></span>
<span id="cb7-16"><a href="#cb7-16" tabindex="-1"></a><span class="co"># 0.1  0.10 0.6352627  0.39780747   0.8410408</span></span>
<span id="cb7-17"><a href="#cb7-17" tabindex="-1"></a><span class="co"># 0.11 0.11 0.7000000  0.42005550   0.9213677</span></span></code></pre></div>
<p>Estimating the ED<span class="math inline">\(_{50}\)</span>, a.k.a.
<strong>the target dose</strong>, is done very similarly:</p>
<div class="sourceCode" id="cb8"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb8-1"><a href="#cb8-1" tabindex="-1"></a>ropiTargetCIR <span class="ot">=</span> <span class="fu">quickInverse</span>(bhamou03ropiRates, <span class="at">target=</span><span class="fl">0.5</span>, <span class="at">adaptiveShrink=</span><span class="cn">TRUE</span>)</span>
<span id="cb8-2"><a href="#cb8-2" tabindex="-1"></a>ropiTargetCIR </span>
<span id="cb8-3"><a href="#cb8-3" tabindex="-1"></a><span class="co">#   target      point lower90conf upper90conf</span></span>
<span id="cb8-4"><a href="#cb8-4" tabindex="-1"></a><span class="co"># 1    0.5 0.09383622  0.07837103    0.101341</span></span>
<span id="cb8-5"><a href="#cb8-5" tabindex="-1"></a>levoTargetCIR <span class="ot">=</span> <span class="fu">quickInverse</span>(bhamou03levoRates, <span class="at">target=</span><span class="fl">0.5</span>, <span class="at">adaptiveShrink=</span><span class="cn">TRUE</span>)</span>
<span id="cb8-6"><a href="#cb8-6" tabindex="-1"></a>levoTargetCIR</span>
<span id="cb8-7"><a href="#cb8-7" tabindex="-1"></a><span class="co">#   target      point lower90conf upper90conf</span></span>
<span id="cb8-8"><a href="#cb8-8" tabindex="-1"></a><span class="co"># 1    0.5 0.06842105  0.05904391  0.09233012</span></span></code></pre></div>
<p>You can also do the estimation single-step from the <code>x, y</code>
data; the functions will create a <code>doseResponse</code> object on
the fly.</p>
<div id="notes" class="section level3">
<h3>Notes</h3>
<ul>
<li>The target-dose estimate appears under the word <code>point</code>:
0.0938 for ropivacaine and 0.0684 for levobupivacaine.</li>
<li>We specify the target response-rate as a fraction, via the
<code>target</code> argument.</li>
<li>Default CIs are 90% rather than 95%, due to the large variability
and limited confidence in these typically small-sample experiments. To
change it use the <code>conf</code> argument.</li>
<li>The <code>adaptiveShrink</code> option performs an empirical
correction of the bias induced by the adaptive design, a bias discovered
and described recently by Flournoy and Oron.<a href="#fn6" class="footnote-ref" id="fnref6"><sup>6</sup></a> This type of bias is
induced not just by UD designs, but also by model-based adaptive designs
such as the Continual Reassessment Method. It is minimal near the target
dose, but flares out to substantial magnitudes in both directions.
<strong>Because of this bias, we strongly recommend to <em>not</em>
estimate any target except 0.5 <em>(or a value very close to 0.5)</em>
from these data, except for exploratory/illustrative purposes.</strong>
The correction serves mostly to provide better CI coverage for the
target dose estimate.</li>
</ul>
<p>Let us calculate 83% CIs, to evaluate the evidence for different
potencies via the overlapping-intervals method.</p>
<div class="sourceCode" id="cb9"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb9-1"><a href="#cb9-1" tabindex="-1"></a>ropi83 <span class="ot">=</span> <span class="fu">quickInverse</span>(bhamou03ropiRates, <span class="at">target=</span><span class="fl">0.5</span>, <span class="at">adaptiveShrink=</span><span class="cn">TRUE</span>, <span class="at">conf=</span><span class="fl">0.83</span>)</span>
<span id="cb9-2"><a href="#cb9-2" tabindex="-1"></a>ropi83</span>
<span id="cb9-3"><a href="#cb9-3" tabindex="-1"></a><span class="co">#   target      point lower83conf upper83conf</span></span>
<span id="cb9-4"><a href="#cb9-4" tabindex="-1"></a><span class="co"># 1    0.5 0.09383622  0.07966513   0.1000783</span></span>
<span id="cb9-5"><a href="#cb9-5" tabindex="-1"></a>levo83 <span class="ot">=</span> <span class="fu">quickInverse</span>(bhamou03levoRates, <span class="at">target=</span><span class="fl">0.5</span>, <span class="at">adaptiveShrink=</span><span class="cn">TRUE</span>, <span class="at">conf=</span><span class="fl">0.83</span>)</span>
<span id="cb9-6"><a href="#cb9-6" tabindex="-1"></a>levo83</span>
<span id="cb9-7"><a href="#cb9-7" tabindex="-1"></a><span class="co">#   target      point lower83conf upper83conf</span></span>
<span id="cb9-8"><a href="#cb9-8" tabindex="-1"></a><span class="co"># 1    0.5 0.06842105  0.06038051   0.0867241</span></span></code></pre></div>
<p>Paradoxically, despite using a point-estimation method very close to
Pace and Stylianou’s (CIR is a minor upgrade of IR), we reach a
conclusion similar to the original authors: <strong>the 83% confidence
intervals do overlap, suggesting no evidence for a difference in
potency</strong> at the <span class="math inline">\(\alpha=0.05\)</span>
level.</p>
<p>Indeed, our point estimates are very similar to the Pace-Stylianou
reanalysis, and so is our estimated levo/ropi potency ratio (1.37, quite
a bit higher than Benhamou et al.’s 1.19). <strong>Where we part ways
with Pace and Stylianou - dramatically - is indeed the confidence
intervals for which our method is quite different.</strong> Pace and
Stylianou used an adaptation of the bootstrap, whereas we use an
analytical approach based on Morris’ theoretical work with intervals for
datasets with monotone dose-response data,<a href="#fn7" class="footnote-ref" id="fnref7"><sup>7</sup></a> the Delta method, and
additional modifications to adapt to typical dose-finding data
limitations.</p>
<p>Looking in more detail at the two confidence limits with the biggest
difference between our method and the boostrap: their <span class="math inline">\(83\%\)</span> LCL for Ropivacaine is <span class="math inline">\(0.087\)</span> - only 0.6 of a dose-spacing step
below their point estimate - whereas ours is 0.08, nearly 1.5 spacings
below our point estimate. Their Levobupivacaine <span class="math inline">\(83\%\)</span> UCL is <span class="math inline">\(0.081\)</span> (1.3 spacings above point-estimate)
vs. 0.087 (&gt;2 spacings above that estimate). Conceptually, the
bootstrap CIs appear unrealistically narrow given the amount of
information available - only 39 dependent binary observations spread
over several doses.</p>
<p>By the way, we can use the same <code>quickInverse()</code> function
to reproduce the Pace-Stylianou <em>point</em> estimates (but not the
CIs, since <code>cir</code> does not implement the bootstrap
approach):</p>
<div class="sourceCode" id="cb10"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb10-1"><a href="#cb10-1" tabindex="-1"></a>PSropiEstimate <span class="ot">=</span> <span class="fu">quickInverse</span>(bhamou03ropiRates, <span class="at">target=</span><span class="fl">0.5</span>, <span class="at">estfun=</span>oldPAVA, <span class="at">conf=</span><span class="fl">0.83</span>)</span>
<span id="cb10-2"><a href="#cb10-2" tabindex="-1"></a>PSropiEstimate</span>
<span id="cb10-3"><a href="#cb10-3" tabindex="-1"></a><span class="co">#   target      point lower83conf upper83conf</span></span>
<span id="cb10-4"><a href="#cb10-4" tabindex="-1"></a><span class="co"># 1    0.5 0.09287671   0.0831183  0.09791556</span></span>
<span id="cb10-5"><a href="#cb10-5" tabindex="-1"></a>PSlevoEstimate <span class="ot">=</span> <span class="fu">quickInverse</span>(bhamou03levoRates, <span class="at">target=</span><span class="fl">0.5</span>, <span class="at">estfun=</span>oldPAVA, <span class="at">conf=</span><span class="fl">0.83</span>)</span>
<span id="cb10-6"><a href="#cb10-6" tabindex="-1"></a>PSlevoEstimate</span>
<span id="cb10-7"><a href="#cb10-7" tabindex="-1"></a><span class="co">#   target      point lower83conf upper83conf</span></span>
<span id="cb10-8"><a href="#cb10-8" tabindex="-1"></a><span class="co"># 1    0.5 0.06846154  0.06240652  0.08618716</span></span></code></pre></div>
<p>Note the argument specifying the <code>oldPAVA()</code> estimation
function (PAVA is the name of the leading algorithm to produce IR
estimates; the package default is <code>cirPAVA()</code>, i.e.,
CIR).</p>
<p>Let us visualize more clearly the CIR estimates, and the rationale
supporting wider intervals from this dataset.</p>
</div>
</div>
<div id="visualizing-cir-on-the-dose-response-plane" class="section level2">
<h2>Visualizing CIR on the Dose-Response Plane</h2>
<p>To construct the full estimated <span class="math inline">\(F(x)\)</span> curves from IR and CIR, we call
<code>cir</code>’s <em>“long-form”</em> forward-estimation
functions:</p>
<div class="sourceCode" id="cb11"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb11-1"><a href="#cb11-1" tabindex="-1"></a>ropiCurveIR <span class="ot">=</span> <span class="fu">oldPAVA</span>(bhamou03ropiRates, <span class="at">full=</span><span class="cn">TRUE</span>)</span>
<span id="cb11-2"><a href="#cb11-2" tabindex="-1"></a>ropiCurveCIR <span class="ot">=</span> <span class="fu">cirPAVA</span>(bhamou03ropiRates, <span class="at">target=</span><span class="fl">0.5</span>, <span class="at">adaptiveShrink=</span><span class="cn">TRUE</span>, <span class="at">full=</span><span class="cn">TRUE</span>)</span>
<span id="cb11-3"><a href="#cb11-3" tabindex="-1"></a>levoCurveIR <span class="ot">=</span> <span class="fu">oldPAVA</span>(bhamou03levoRates, <span class="at">full=</span><span class="cn">TRUE</span>)</span>
<span id="cb11-4"><a href="#cb11-4" tabindex="-1"></a>levoCurveCIR <span class="ot">=</span> <span class="fu">cirPAVA</span>(bhamou03levoRates, <span class="at">target=</span><span class="fl">0.5</span>, <span class="at">adaptiveShrink=</span><span class="cn">TRUE</span>, <span class="at">full=</span><span class="cn">TRUE</span>)</span></code></pre></div>
<p>With <code>full=TRUE</code>, each of these returns a list of three
<code>doseResponse</code> objects. Here’s one example:</p>
<div class="sourceCode" id="cb12"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb12-1"><a href="#cb12-1" tabindex="-1"></a>levoCurveCIR</span>
<span id="cb12-2"><a href="#cb12-2" tabindex="-1"></a><span class="co"># $output</span></span>
<span id="cb12-3"><a href="#cb12-3" tabindex="-1"></a><span class="co">#         x         y weight</span></span>
<span id="cb12-4"><a href="#cb12-4" tabindex="-1"></a><span class="co"># 0.05 0.05 0.1666667      2</span></span>
<span id="cb12-5"><a href="#cb12-5" tabindex="-1"></a><span class="co"># 0.06 0.06 0.2777778      8</span></span>
<span id="cb12-6"><a href="#cb12-6" tabindex="-1"></a><span class="co"># 0.07 0.07 0.5416667     11</span></span>
<span id="cb12-7"><a href="#cb12-7" tabindex="-1"></a><span class="co"># 0.08 0.08 0.5542328      6</span></span>
<span id="cb12-8"><a href="#cb12-8" tabindex="-1"></a><span class="co"># 0.09 0.09 0.5705255      3</span></span>
<span id="cb12-9"><a href="#cb12-9" tabindex="-1"></a><span class="co"># 0.1  0.10 0.6352627      5</span></span>
<span id="cb12-10"><a href="#cb12-10" tabindex="-1"></a><span class="co"># 0.11 0.11 0.7000000      4</span></span>
<span id="cb12-11"><a href="#cb12-11" tabindex="-1"></a><span class="co"># </span></span>
<span id="cb12-12"><a href="#cb12-12" tabindex="-1"></a><span class="co"># $input</span></span>
<span id="cb12-13"><a href="#cb12-13" tabindex="-1"></a><span class="co">#         x         y weight</span></span>
<span id="cb12-14"><a href="#cb12-14" tabindex="-1"></a><span class="co"># 0.05 0.05 0.1666667      2</span></span>
<span id="cb12-15"><a href="#cb12-15" tabindex="-1"></a><span class="co"># 0.06 0.06 0.2777778      8</span></span>
<span id="cb12-16"><a href="#cb12-16" tabindex="-1"></a><span class="co"># 0.07 0.07 0.5416667     11</span></span>
<span id="cb12-17"><a href="#cb12-17" tabindex="-1"></a><span class="co"># 0.08 0.08 0.7857143      6</span></span>
<span id="cb12-18"><a href="#cb12-18" tabindex="-1"></a><span class="co"># 0.09 0.09 0.3750000      3</span></span>
<span id="cb12-19"><a href="#cb12-19" tabindex="-1"></a><span class="co"># 0.1  0.10 0.4166667      5</span></span>
<span id="cb12-20"><a href="#cb12-20" tabindex="-1"></a><span class="co"># 0.11 0.11 0.7000000      4</span></span>
<span id="cb12-21"><a href="#cb12-21" tabindex="-1"></a><span class="co"># </span></span>
<span id="cb12-22"><a href="#cb12-22" tabindex="-1"></a><span class="co"># $shrinkage</span></span>
<span id="cb12-23"><a href="#cb12-23" tabindex="-1"></a><span class="co">#               x         y weight</span></span>
<span id="cb12-24"><a href="#cb12-24" tabindex="-1"></a><span class="co"># 0.05 0.05000000 0.1666667      2</span></span>
<span id="cb12-25"><a href="#cb12-25" tabindex="-1"></a><span class="co"># 0.06 0.06000000 0.2777778      8</span></span>
<span id="cb12-26"><a href="#cb12-26" tabindex="-1"></a><span class="co"># 0.07 0.07000000 0.5416667     11</span></span>
<span id="cb12-27"><a href="#cb12-27" tabindex="-1"></a><span class="co"># 0.08 0.08928571 0.5659014     14</span></span>
<span id="cb12-28"><a href="#cb12-28" tabindex="-1"></a><span class="co"># 0.11 0.11000000 0.7000000      4</span></span></code></pre></div>
<ul>
<li><code>$output</code> is the estimates at the original doses
<em>(which is what <code>quickIsotone()</code> returns sans the
CIs)</em>,</li>
<li><code>$input</code> is the incoming data, and</li>
<li><code>$shrinkage</code> is the output at the doses where the
algorithm makes the pooled estimates (then interpolated to generate
<code>$output</code>). IOW, <strong><code>$shrinkage</code> is the
actual regression curve found by the algorithm.</strong> With
<code>oldPAVA()</code>, this component will always be identical to
<code>$output</code>.</li>
</ul>
<p>We end with the dose-response plots, the regression curves and the
target estimates, with the two arms aligned and arranged vertically to
help visualize the CI overlap.</p>
<p><strong>As can be seen below, in <code>cir</code> this takes quite a
bit of coding. In the new <code>upndown</code> package dedicated to
up-and-down designs <em>(currently in beta version on GitHub
<code>assaforon/upndown</code>, and soon also on CRAN)</em>, most of
what you see in the plot can be achieved in a single command with the
<code>drplot()</code> utility</strong> (which does of course rely on
<code>cir</code> functions in the backend).</p>
<div class="sourceCode" id="cb13"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb13-1"><a href="#cb13-1" tabindex="-1"></a><span class="fu">par</span>(<span class="at">mfrow=</span><span class="fu">c</span>(<span class="dv">2</span>,<span class="dv">1</span>), <span class="at">las=</span><span class="dv">1</span>, <span class="at">mar=</span><span class="fu">c</span>(<span class="dv">4</span>,<span class="dv">4</span>,<span class="dv">4</span>,<span class="dv">1</span>)) <span class="co"># image format parameters</span></span>
<span id="cb13-2"><a href="#cb13-2" tabindex="-1"></a><span class="fu">plot</span>(bhamou03ropiRates, <span class="at">xlab=</span><span class="st">&quot;Concentration (%)&quot;</span>, </span>
<span id="cb13-3"><a href="#cb13-3" tabindex="-1"></a>  <span class="at">ylab=</span><span class="st">&quot;Proportion Effective&quot;</span>, <span class="at">main=</span><span class="st">&#39;Ropivacaine Arm&#39;</span>, </span>
<span id="cb13-4"><a href="#cb13-4" tabindex="-1"></a>  <span class="at">ylim=</span><span class="dv">0</span><span class="sc">:</span><span class="dv">1</span>, <span class="at">xlim=</span><span class="fu">c</span>(<span class="fl">0.05</span>, <span class="fl">0.12</span>), <span class="at">dosevals =</span> (<span class="dv">5</span><span class="sc">:</span><span class="dv">12</span>)<span class="sc">/</span><span class="dv">100</span>)</span>
<span id="cb13-5"><a href="#cb13-5" tabindex="-1"></a><span class="co"># Adding IR and CIR lines with the same colors/lines as article’s Fig. 4</span></span>
<span id="cb13-6"><a href="#cb13-6" tabindex="-1"></a><span class="fu">lines</span>(y<span class="sc">~</span>x, <span class="at">data=</span>ropiCurveIR<span class="sc">$</span>output, <span class="at">lty=</span><span class="dv">2</span>)</span>
<span id="cb13-7"><a href="#cb13-7" tabindex="-1"></a><span class="fu">lines</span>(y<span class="sc">~</span>x, <span class="at">data=</span>ropiCurveCIR<span class="sc">$</span>shrinkage, <span class="at">col=</span><span class="st">&#39;blue&#39;</span>,<span class="at">lwd=</span><span class="dv">2</span>)</span>
<span id="cb13-8"><a href="#cb13-8" tabindex="-1"></a><span class="co"># Showing the CIR estimate, and confidence interval as a horizontal line</span></span>
<span id="cb13-9"><a href="#cb13-9" tabindex="-1"></a><span class="fu">points</span>(target <span class="sc">~</span> point, <span class="at">data=</span>ropiTargetCIR, <span class="at">col=</span><span class="st">&#39;purple&#39;</span>, <span class="at">pch=</span><span class="dv">19</span>, <span class="at">cex=</span><span class="dv">2</span>)</span>
<span id="cb13-10"><a href="#cb13-10" tabindex="-1"></a><span class="fu">lines</span>(<span class="fu">c</span>(ropi83<span class="sc">$</span>lower83conf,ropi83<span class="sc">$</span>upper83conf), <span class="fu">rep</span>(<span class="fl">0.5</span>,<span class="dv">2</span>), <span class="at">col=</span><span class="st">&#39;purple&#39;</span>, <span class="at">lwd=</span><span class="dv">2</span>)</span>
<span id="cb13-11"><a href="#cb13-11" tabindex="-1"></a><span class="co"># The estimate appearing in Pace and Stylianou 2007, nudged 0.01 units down:</span></span>
<span id="cb13-12"><a href="#cb13-12" tabindex="-1"></a><span class="fu">points</span>(<span class="fu">I</span>(target<span class="fl">-0.01</span>) <span class="sc">~</span> point, <span class="at">data=</span>PSropiEstimate, <span class="at">cex=</span><span class="dv">2</span>)</span>
<span id="cb13-13"><a href="#cb13-13" tabindex="-1"></a><span class="fu">lines</span>(<span class="fu">c</span>(<span class="fl">0.087</span>, <span class="fl">0.097</span>), <span class="fu">rep</span>(<span class="fl">0.49</span>,<span class="dv">2</span>))</span>
<span id="cb13-14"><a href="#cb13-14" tabindex="-1"></a></span>
<span id="cb13-15"><a href="#cb13-15" tabindex="-1"></a><span class="co"># Adding legend:</span></span>
<span id="cb13-16"><a href="#cb13-16" tabindex="-1"></a><span class="fu">legend</span>(<span class="st">&#39;topleft&#39;</span>, <span class="at">legend=</span><span class="fu">c</span>(<span class="st">&quot;Observed Proportions&quot;</span>, <span class="st">&#39;Isotonic Regression&#39;</span>,</span>
<span id="cb13-17"><a href="#cb13-17" tabindex="-1"></a>                              <span class="st">&#39;Centered Isotonic Regression&#39;</span>, <span class="fu">paste</span>(<span class="fu">c</span>(<span class="st">&#39;CIR&#39;</span>, <span class="dv">2007</span>), <span class="st">&#39;Estimate +/- 83% CI&#39;</span>)),</span>
<span id="cb13-18"><a href="#cb13-18" tabindex="-1"></a>       <span class="at">bty=</span><span class="st">&#39;n&#39;</span>,<span class="at">pch=</span><span class="fu">c</span>(<span class="dv">4</span>,<span class="cn">NA</span>,<span class="cn">NA</span>,<span class="dv">16</span>,<span class="dv">1</span>), <span class="at">col=</span><span class="fu">c</span>(<span class="st">&#39;black&#39;</span>,<span class="st">&#39;black&#39;</span>,<span class="st">&#39;blue&#39;</span>,<span class="st">&#39;purple&#39;</span>, <span class="st">&#39;black&#39;</span>), <span class="at">lty=</span><span class="fu">c</span>(<span class="dv">0</span>,<span class="dv">2</span>,<span class="dv">1</span>,<span class="dv">1</span>,<span class="dv">1</span>))</span>
<span id="cb13-19"><a href="#cb13-19" tabindex="-1"></a></span>
<span id="cb13-20"><a href="#cb13-20" tabindex="-1"></a><span class="do">### Now, second plot for Levobupivacaine</span></span>
<span id="cb13-21"><a href="#cb13-21" tabindex="-1"></a><span class="fu">plot</span>(bhamou03levoRates, <span class="at">xlab=</span><span class="st">&quot;Concentration (%)&quot;</span>, </span>
<span id="cb13-22"><a href="#cb13-22" tabindex="-1"></a>  <span class="at">ylab=</span><span class="st">&quot;Proportion Effective&quot;</span>, <span class="at">main=</span><span class="st">&#39;Levobupivacaine Arm&#39;</span>, </span>
<span id="cb13-23"><a href="#cb13-23" tabindex="-1"></a>  <span class="at">ylim=</span><span class="dv">0</span><span class="sc">:</span><span class="dv">1</span>, <span class="at">xlim=</span><span class="fu">c</span>(<span class="fl">0.05</span>, <span class="fl">0.12</span>), <span class="at">dosevals =</span> (<span class="dv">5</span><span class="sc">:</span><span class="dv">12</span>)<span class="sc">/</span><span class="dv">100</span>)</span>
<span id="cb13-24"><a href="#cb13-24" tabindex="-1"></a></span>
<span id="cb13-25"><a href="#cb13-25" tabindex="-1"></a><span class="fu">lines</span>(y<span class="sc">~</span>x, <span class="at">data=</span>levoCurveIR<span class="sc">$</span>output, <span class="at">lty=</span><span class="dv">2</span>)</span>
<span id="cb13-26"><a href="#cb13-26" tabindex="-1"></a><span class="fu">lines</span>(y<span class="sc">~</span>x, <span class="at">data=</span>levoCurveCIR<span class="sc">$</span>shrinkage, <span class="at">col=</span><span class="st">&#39;blue&#39;</span>,<span class="at">lwd=</span><span class="dv">2</span>)</span>
<span id="cb13-27"><a href="#cb13-27" tabindex="-1"></a><span class="fu">points</span>(target <span class="sc">~</span> point, <span class="at">data=</span>levoTargetCIR, <span class="at">col=</span><span class="st">&#39;purple&#39;</span>, <span class="at">pch=</span><span class="dv">19</span>, <span class="at">cex=</span><span class="dv">2</span>)</span>
<span id="cb13-28"><a href="#cb13-28" tabindex="-1"></a><span class="fu">lines</span>(<span class="fu">c</span>(levo83<span class="sc">$</span>lower83conf,levo83<span class="sc">$</span>upper83conf), <span class="fu">rep</span>(<span class="fl">0.5</span>,<span class="dv">2</span>), <span class="at">col=</span><span class="st">&#39;purple&#39;</span>, <span class="at">lwd=</span><span class="dv">2</span>)</span>
<span id="cb13-29"><a href="#cb13-29" tabindex="-1"></a><span class="fu">points</span>(<span class="fu">I</span>(target<span class="fl">-0.01</span>) <span class="sc">~</span> point, <span class="at">data=</span>PSlevoEstimate, <span class="at">cex=</span><span class="dv">2</span>)</span>
<span id="cb13-30"><a href="#cb13-30" tabindex="-1"></a><span class="fu">lines</span>(<span class="fu">c</span>(<span class="fl">0.059</span>, <span class="fl">0.081</span>), <span class="fu">rep</span>(<span class="fl">0.49</span>,<span class="dv">2</span>))</span></code></pre></div>
<p><img role="img" src="data:image/png;base64,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" width="500" height="1000" /></p>
<div id="notes-1" class="section level3">
<h3>Notes</h3>
<ul>
<li><p>The 2007 estimates were shifted slightly downward in the plot, to
make them visible.</p></li>
<li><p>Referring back to the “murky” picture around target in the
Levobupivacaine dose-response plots, we see that both IR (black dashes)
and CIR (solid blue) pool the observations from <span class="math inline">\(x = 0.08, 0,09, 0.10\)</span> into a single
weighted average <span class="math inline">\(y\)</span> value, which is
only slightly higher than the estimate at <span class="math inline">\(x
= 0.07.\)</span> The main difference is that IR creates a flat “stretch”
with that pooled <span class="math inline">\(y\)</span> value, whereas
CIR also pools along the <span class="math inline">\(x\)</span> axis
into a single point on the dose-response plane. So both these
nonparametric algorithms <em>“convert the murkiness”</em> into
concluding (with very limited confidence, given the overall small <span class="math inline">\(n\)</span>) that <strong><span class="math inline">\(F(x)\)</span> is very shallow for a long stretch,
right above the <span class="math inline">\(y = 0.5\)</span> target
response rate.</strong></p></li>
<li><p>We see how the CIR intervals stretch to accommodate this
shallowness. Indeed, <strong>our confidence-interval method for inverse
estimation is driven directly by local slope around target</strong>,
which we believe is the more realistic approach.</p></li>
<li><p>Take in particular the Levobupivacaine plot at <span class="math inline">\(x = 0.10\)</span>. The CIR estimate of <span class="math inline">\(F(x)\)</span> there is 0.635. The IR estimate
which is what Pace and Stylianou used to inform their bootstrap, is
0.571 - even closer to the <span class="math inline">\(50\%\)</span>
study target-rate, and statistically indistinguishable from it at these
sample sizes. Yet, <span class="math inline">\(0.10\)</span> lies not
only outside the 2007 article bootstrap’s <span class="math inline">\(83\%\)</span> CI, but also outside their <span class="math inline">\(95\%\)</span> CI (which is <span class="math inline">\(0.058, 0.095\)</span>). This suggests that the
bootstrap intervals are substantially too short.</p></li>
<li><p>Prior to <code>cir</code> package version 2.3.0, the estimated
slope informing the CI was the same to the right and left of target, and
hence CIs were usually near-symmetric <em>(and in this particular
example, much shorter)</em>. We now estimate different <em>“left”</em>
and <em>“right”</em> slopes. To revert to the single-slope version, use
the argument <code>slopeRefinement = FALSE</code> in your
<code>quickInverse()</code> call.<br />
</p></li>
<li><p>In this demonstration the CIR curves differ from the ordinary IR
curves not only in the CIR algorithm that “shrinks” horizontal intervals
to single points, but also in the bias correction found by Flournoy and
Oron (2020) and mentioned earlier. In principle this correction is
compatible with both methods, but here we applied it only to CIR,
because it did not exist at the time of Pace and Stylianou’s
article.</p></li>
</ul>
</div>
</div>
<div id="references" class="section level2">
<h2>References</h2>
</div>
<div class="footnotes footnotes-end-of-document">
<hr />
<ol>
<li id="fn1"><p>Benhamou D, Ghosh C, Mercier FJ. A Randomized Sequential
Allocation Study to Determine the Minimum Effective Analgesic
Concentration of Levobupivacaine and Ropivacaine in Patients Receiving
Epidural Analgesia for Labor. Anesthesiology. 2003;99(6):1383-1386.<a href="#fnref1" class="footnote-back">↩︎</a></p></li>
<li id="fn2"><p>Pace NL, Stylianou MP. Advances in and Limitations of
Up-and-down Methodology: A Précis of Clinical Use, Study Design, and
Dose Estimation in Anesthesia Research. Anesthesiology.
2007;107(1):144-152.<a href="#fnref2" class="footnote-back">↩︎</a></p></li>
<li id="fn3"><p>Oron AP, Flournoy N. Centered Isotonic Regression: Point
and Interval Estimation for Dose-Response Studies. Stat Biopharm Res.
2017;9(3):258-267.<a href="#fnref3" class="footnote-back">↩︎</a></p></li>
<li id="fn4"><p>Oron AP, Souter MJ, Flournoy N. Understanding Research
Methods: Up-and-down Designs for Dose-finding. <em>Anesthesiology</em>
2022; 137:137–50. See also the online supplement.<a href="#fnref4" class="footnote-back">↩︎</a></p></li>
<li id="fn5"><p>Payton ME, Greenstone MH, Schenker N. Overlapping
confidence intervals or standard error intervals: What do they mean in
terms of statistical significance? J Insect Sci. 2003;3(1).<a href="#fnref5" class="footnote-back">↩︎</a></p></li>
<li id="fn6"><p>Flournoy N, Oron AP. Bias induced by adaptive
dose-finding designs. J Appl Stat. 2020;47(13-15):2431-2442.<a href="#fnref6" class="footnote-back">↩︎</a></p></li>
<li id="fn7"><p>Morris MD. Small-Sample Confidence Limits for Parameters
under Inequality Constraints with Application to Quantal Bioassay.
Biometrics. 1988;44:1083-1092.<a href="#fnref7" class="footnote-back">↩︎</a></p></li>
</ol>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
